Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry

Glaukos Corporation191 enrolled

Overview

The purpose of this study is to observe the safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery in subjects with mild to moderate open-angle glaucoma.

Study Type

OBSERVATIONAL

Enrollment

191

Conditions

Primary Open-angle Glaucoma

Interventions

iStentDEVICE

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Consecutive subjects in whom implantation of the iStent is attempted Exclusion Criteria: * Please refer to approved indications in Directions for Use

Locations (18)

Unnamed facility

Chico, California, United States

Unnamed facility

Huntington Beach, California, United States

Unnamed facility

Napa, California, United States

Outcomes

Primary Outcomes

Rate of sight-threatening adverse events

Time frame: 36 months

Secondary Outcomes

Other ocular adverse events

Time frame: 36 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.